MedTech Dive2d agobullish
Cordis wins FDA approval for sirolimus-eluting balloonThe approval gives physicians an alternative to uncoated balloons and Boston Scientific’s paclitaxel-coated device.
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
The approval gives physicians an alternative to uncoated balloons and Boston Scientific’s paclitaxel-coated device.
Johnson & Johnson expects U.S. physicians to perform the first procedures with the device this summer as it starts a phased commercial rollout.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.